1st Nov 2006 Since its inception in 2001, Vision RT has developed a world class team to deliver state of the art 3D surface imaging products for radiotherapy. The Company is now delighted to announce the non-executive appointment of Jack Coats to its board of directors. Jack Coats is a senior executive with specialist expertise in radiotherapy sales management and the US market in particular. Jack Coats resides in the USA and is currently Director of Business Development (Nanobiology) at FEI. Jack has held senior executive roles in the radiotherapy industry for almost thirty years. Jack was formerly Vice President of Sales and Integrated Systems at Varian Medical Systems. More recently, Jack was President of Nucletron Inc in which capacity he built up and managed all operational activities for Nucletron in the Americas. Jack brings world class market knowledge to the Company, is highly regarded in the radiotherapy sector, and maintains personal relationships with many of its key authorities and opinion leaders. Jack’s appointment to the Board further strengthens Vision RT’s sector profile and provides additional sales and marketing expertise to the Company. Company Background
Vision RT Limited is a UK based company that has developed a novel approach to enhance the crucial process of patient setup and surveillance during radiotherapy treatment of cancer. Vision RT’s revolutionary product, AlignRT®, utilises a proprietary real-time 3D surface imaging technology to provide exceptional speed and accuracy designed to improve the efficacy and precision of radiotherapy treatment.
| 